Longer and longer: the ever lengthening loan agreement
Technology dealmaking has continued apace in 2020 as M&A investors take advantage of the sector's resilience to transact
The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis
Low prices and excess supply have pushed oil & gas balance sheets to the brink, which means raising traditional debt will remain difficult and restructurings are expected
Practical advice on restructuring processes and considerations
Remote working, online shopping and telemedicine have shielded the technology sector from the worst effects of COVID-19 lockdowns
The year started strongly for many nations in Latin America, but coronavirus has heavily impacted the M&A market.